Cancer Costs and Economic Burden

Abstract

Cancer and its treatment result in the harm of economic resources and opportunities for patients, families, employers, and society. These losses include fiscal loss, morbidity, reduced excellence of life, and premature death. When estimating the economic burden of disease, the monetary valuation of resources wont to treat, so the loss of opportunities because of illness is measured as costs and finds out the components.